SOM230 LAR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SOM230 LAR, covering 2018-02-05 to 2018-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size [Phase 2]